Abstract
Background
The disabling symptoms, various food and fluid restrictions, restrictions to social life and stigma and taboos attached to Chronic Kidney Disease (CKD), have shown to pose a significant bearing on a patient’s Quality of Life (QOL). In the present study the Kidney Disease QOL-Short Form (KDQOL-SF™) was culturally adapted, modified and translated into Sinhala and validity and reliability were assessed.
Method
The process to culturally adapt the Kidney Disease Specific Component (KDSC) of KDQOL-SF™ was carried out by the modified Delphi process with a group of experts. The construct validity of the KDSC was assessed using Exploratory Factor Analysis (EFA). Appraising construct validity of SF-36 component of KDQOL-SF™ was done by assessing the convergent and discriminant validity using the Multitrait-Multimethod Matrix technique (MTMM). Randomly selected 250 CKD patients attending the five renal clinics in Polonnauwa were used to assess the construct validity. To assess the test-retest reliability of the instrument, within a period of one week, 30 randomly selected study participants were visited at their households.
Results
Two hundred and fifty adults with documented evidence of CKD participated. The EFA carried out using principal component factoring method and rotated by Varimax orthogonal method resulted in 14 factors with Eigen values ranging from 1.062–8.746. This 14 factor model explained 84.1% of total variance of the initial system. The communalities extracted for domains were all close to one. All the items were loaded to one or more domains with factor coefficients of more than 0.4, not requiring any of the items to be dropped. Few items which showed similarly high factor coefficients in more than one factor were assigned to a factor ensuring the pattern in the theoretical framework of the questionnaire based on expert opinion and vigorous analysis of literature.
Convergent and divergent validity assessed using MTMM, revealed satisfactory construct validity. Cronbach’s alpha of all domains of KDQOL-SF™ except for cognitive function and Social function, exceeded Nunnally's criteria of 0.7. The Intra class Correlation Coefficients (ICC) were more than 0.8 for all the domains, which indicated good test re-test reliability.
Conclusions
KDQOL-SF™ is a valid and reliable instrument which can be used to assess QOL of CKD patients in Sri Lanka.
Keywords: Chronic kidney disease, Quality of life, Sri Lanka, Chronic kidney disease of unknown aetiology
Background
The prevalence of Chronic Kidney Disease (CKD) is increasing globally, though regional disparities exist. It is increasing worldwide at an annual growth rate of 8% [1]. Epidemiologic studies have shown that the incidence of kidney diseases is higher in the developing countries than in the developed world.
Quality of Life (QOL) is a subjective phenomenon which can be influenced by a person’s experience, beliefs and expectations [2]. Despite enormous advances in treatment modalities, the disabling symptoms, various food and fluid restrictions, restrictions to social life and stigma and taboos attached to CKD, have shown to pose a significant bearing on a patient’s QOL [3].
Several studies demonstrated strong relationship between reduced QOL and increased morbidity and mortality related to CKD. The importance of including QOL indicators to the clinical management of CKD patients has been highlighted world over [4–7].
Various tools have been developed to quantitatively measure disease related QOL, but these tools need disease and country specific validation [8]. The Kidney Disease Quality Of Life-Short Form (KDQOL-SF™) version 1.3 questionnaire is a tool used to measure the QOL of kidney disease patients. It is a self-administered tool developed in 1995 by Hays et al., specifically to assess QOL among CKD patients. It has been translated into several languages including Dutch, Korean, Italian, Iranian, Brazilian, and Japanese and has been validated in various countries.
Evaluation of QOL among CKD patients in Sri Lanka can add new insight into the management of the disease as it allows the quantification of the disease consequences according to the patient’s perception and enables adjustment of medical decisions to their physical, emotional, and social needs [9].
In the present study the KDQOL-SF™ version 1.3 was culturally adapted, modified and translated into Sinhala, which is the most common language spoken in Sri Lanka. This Sinhala version of the KDQOL-SF™ 1.3 was subsequently tested among a representative sample of Sri Lankan CKD patients to determine the psychometric properties, reliability, and validity for use in the assessment of QOL among CKD patients.
Methods
Structure of KDQOL-SF™ version 1.3
KDQOL-SF has two components; Kidney Disease Specific Component and SF-36. Of the total 81 questions in 19 domains, 43 questions assess 11 kidney disease specific components of QOL and SF-36 questionnaire in which the 36 questions assess the general health related QOL in eight domains.
The 11 domains of Kidney Disease Specific Component are: symptom/problem list (12 items), effects of kidney disease (8 items), burden of kidney disease (4 items), cognitive function (3 items), quality of social interaction (3 items), sexual function (2 items), sleep (4 items), social support (2 items), work status (2 items), patient satisfaction (1 item), and dialysis staff encouragement (2 items). SF-36 includes 36 items that measure eight domains and the eight domains are: physical function (10 items), role limitations caused by physical problems (4 items), role limitations caused by emotional problems (3 items), pain (2 items), general health perceptions (5 items), social function (2 items), emotional well-being (5 items), and energy/fatigue (4 items). The final item, the overall health rate item, asks the respondents to rate their health on a 0–10 response scale. Different questions have different answer options, which range from two to seven. When scoring, each question is scored in a scale ranging from 0 (worst health) to 100 (best health). All items in a domain are summed up and averaged to give an average score for each domain which ranges from 0 (worst health) to 100 (best health).
Cultural adaptation and modification of kidney disease specific component of KDQOL-SF™
Considering the fact that Sri Lanka is a developing country, it is necessary that some of the words and examples used in the Kidney Disease Specific Component of KDQOL-SF™ undergo cultural adaptation before it can be applied to Sri Lanka. Therefore, the Kidney Disease Specific Component of KDQOL-SF™ was subjected to cultural adaptation and modification in the present study. The culturally adapted Kidney Disease Specific Component of KDQOL-SF™ was subjected to pre-testing and assessments of content and face validity and construct validity as well as reliability.
The process to culturally adapt the Kidney Disease Specific Component of KDQOL-SF™ was carried out by the modified Delphi process [10] with a group of experts (n = 15) from the fields of nephrology, general medicine, psychiatry and community medicine.
The experts were requested to review each items in the questionnaire and to indicate whether the item should be retained in the questionnaire to assess the HRQOL of CKD patients in Sri Lanka. If they decided that the item should retain, then they were asked to assess the cultural appropriateness of the words and examples used in the items in a 1–5 scale. If they assign a score less than three, they were further asked to indicate their suggestion on how the item should be modified to improve the cultural appropriateness. In the first round, they were also asked to indicate any additional kidney disease specific items/areas they think are relevant to HRQOL of CKD patients in Sri Lanka
Agreement of more than 50% of the expert panel to remove an item, was taken as the cut off to remove an item from the questionnaire. An average score of four or above was taken as an agreement of the experts on cultural appropriateness of an item. If the average score of an item was less than four, the modifications suggested by the experts to improve the cultural appropriateness were reviewed and the best option was selected.
The communications were made via individually addressed electronic mails and the identity of individual panelists was not revealed to the others until the end of the process.
The results of the first round of iteration showed that more than 50% of the experts indicating removal of the item 13, “Problems with your catheter site”, and all the other items were marked as culturally appropriate, to be used to assess QOL of CKD patients in Sri Lanka.
The rating for each item and all additional remarks were summarized by the principal investigator (PI). In the first round, the mean scores for each item ranged from 3.44 to 5.00. Items 01, 20, 27, 36, 43, 44 and 45 had a mean score less than 4.0 indicating that the wordings should be modified to make it more culturally appropriate. These items were modified by reviewing the modifications suggested by the experts (Table 1).
Table 1.
Item number | Previous item | Modified/new item |
---|---|---|
01 | Soreness in your muscles | Muscle aches and pains |
20 | Your sex life | Having sexual relationships with your partner |
27 | Does your health keep you from working at a paying job | Do you have to stay away from your job due to your ill health? |
36 | Becoming sexually aroused | Desire for sexual activity |
43 | Dialysis staff encourage me to be as independent as possible | Hospital staff encourage me to be as independent as possible |
44 | Dialysis staff support me in coping with my kidney disease | Hospital staff support me in coping with my kidney disease |
45 | Think about the care you receive for kidney dialysis. | Think about the care you receive for kidney disease. |
In the second round, the modified tool with the mean scores of each item in the first round was communicated to the expert panel. The expert panel was asked to rate the cultural appropriateness of the words used in the modified items in a 1–5 scale. Upon summarizing the scores of each modified item, it was shown that the mean score of all the items were above 4.0.
Translation of kidney disease specific component of KDQOL-SF™
Two translators, both with a high level of proficiency in English and Sinhala, independently translated the questionnaire into Sinhala. The two Sinhala translated versions were then reviewed by an independent expert proficient in both English and Sinhala languages. The items which were agreed upon were accepted for forward translation. Two bilingual translators, both with a high level of proficiency in English and Sinhala, independently translated the provisional forward translation back into English without referring to the original English version. The two English translated versions were then reviewed by an independent expert, proficient in both English and Sinhala languages.
Pretesting of the KDQOL-SF™
The SF-36 component has been previously culturally adapted, translated to Sinhalese and validated among different population groups in Sri Lanka [11]. Thus, the already validated SF-36 component of KDQOL-SF™ was pre-tested among a group of CKD patients. Further, its content and face validity and convergent-discriminant validity as well as reliability were appraised in the present study.
Pre-testing the KDQOL-SF™ among ten CKD patients was done using the services of the renal clinic at Maligawatta National Institute for Nephrology Dialysis and Transplantation in the district of Colombo. Administration of each questionnaire was followed by a structured interview conducted by the PI. Based on the interviews, a few modifications were done to the instructions stated for some items.
Appraising construct validity and reliability of the KDQOL-SF™
A multidisciplinary panel of experts appraised and confirmed the face, content and consensual validity of the tool. As the factorial validity of the Kidney Disease Specific Component of KDQOL-SF is not established in many different settings elsewhere, it was decided to carry out Exploratory Factor Analysis (EFA) on the observations of the validation study to identify the common factors of the original system of 43 dimension. Prior to EFA, factorability of the data was assessed by Bartlett’s test of sphericity, which showed that the population correlation matrix is significantly different from the identity matrix (Bartlett Test Statistics 3907.89; p < 0.001). The Kaiser-Meyer-Olkin measure which is an index for comparing the magnitude of the observed correlation matrix to the magnitude of the partial correlation matrix (0.791) was greater than the recommended value for factor analysis. Also overall reliability index was assessed using Cronbach’s alpha (0.889) and it was greater than 0.8. Thus the above results confirmed that the data set can be used for factor analysis.
Appraising construct validity of SF 36 component of KDQOL-SF™ was done by assessing the convergent and discriminant validity. To assess convergent and discriminant validity of SF-36 component of KDQOL-SF™, World Health Organization QOL –BREF (WHOQOL-BREF) which is a generic tool to assess QOL and which has been validated in Sri Lanka was used [12]. Comparable domains of both tools were used for the assessment of convergent and discriminant validity. Convergent and discriminant validity were measured using the Multitrait-Multimethod Matrix technique (MTMM).
The three hospitals in Polonnaruwa district, namely; District General Hospital Polonnauwa, Base Hospital Medirigiriya and Divisional Hospital Hingurakgoda, conduct five renal clinics per week. To assess the construct validity, 50 CKD patients were randomly selected from each above said five clinics using the clinic register as the sampling frame. A total of 250 patients were thus selected. The required number of 250 study participants were distributed equally and from each clinic, 50 eligible study participants were selected using convenient sampling method. The patients who are over 18 years old and who were diagnosed as having CKD, irrespective of whether the etiology is known or unknown, by a consultant nephrologist or by a consultant physician were included in the study. The patients who had a previous renal transplantation and patients who were critically ill, from whom reliable information cannot be acquired were excluded from the study.
To assess the test-retest reliability of the study instrument, within a period of one week, 30 randomly selected study participants were visited at their households by the data collectors. Test re-test reliability of both components of KDQOL-SF™ was assessed using Intra class Correlation Coefficient (ICC) and a value of 0.70 or greater was considered as satisfactory reliability [13].
Internal consistency of both components of KDQOL-SF™ was assessed by calculating the Cronbach’s alpha. Internal consistency estimates for each of the domains of a magnitude of 0.7 or greater according to Nunnally’s criterion, was considered as satisfactory internal consistency [14].
Quality of data
All possible measures were taken to ensure the quality of information gathered while collecting data. Data collectors were experienced in functioning as data collectors for many local and international studies done among CKD patients in the NCP and further they were trained by the PI to ensure the quality of the data collected. The study participants were informed of the purpose of the study, nature of the study and the fact that the data collected would be confidential and accessible only to the PI.
Data entry and re-checking was done by the PI. Any inconsistent or missing responses were traced back to the questionnaires and were corrected.
Data analysis
Scoring of the two study instruments (KDQOL-SF™ and WHOQOL-BREF) were carried out according to the instructions provided by the original authors. The Statistical Package for the Social Sciences (SPSS) analytic software version 20 was used for the analysis.
Results
Basic information
Two hundred and fifty adults with documented evidence of CKD participated in the validation study. The mean age of the participants was 57.7 years (SD 10.6). The majority of the participants were females (n = 145; 58.0%). A majority of those who were currently employed in the study population, were farmers (n = 85; 73.3%). Details of the CKD conditions were obtained from the medical records, which showed that the mean number of years since the diagnosis of CKD was 6.3 years (SD = 3.7). The mean eGFR value was 29.3 ml/min/1.73 m2 (SD = 19.0). A majority (n = 179; 71.6%) were in either CKD category three or category four. Documented Chronic Kidney Disease of Unknown origin (CKDu) was seen in 20.8% (n = 52). For more details refer Table 2. The descriptive statistics of the KDQOL-SF™ are summarized in Table 3.
Table 2.
Socio demographic characteristics | (N = 250) n | Percent | |
---|---|---|---|
Age categories (Years) | 18–40 | 17 | 6.8 |
41–60 | 130 | 52.0 | |
61–80 | 103 | 41.2 | |
Sex | Male | 105 | 42.0 |
Female | 145 | 58.0 | |
Highest level of education | Never gone to school | 24 | 9.6 |
Primary education | 93 | 37.2 | |
Junior secondary education | 95 | 38.0 | |
Senior secondary education | 32 | 12.8 | |
Collegiate | 05 | 2.0 | |
University | 01 | 0.4 | |
GFR category | Stage 1 | 48 | 19.2 |
Stage 2 | 11 | 4.4 | |
Stage 3 | 71 | 28.4 | |
Stage 4 | 108 | 43.2 | |
Stage 5 (Non dialysis) | 09 | 3.6 | |
Stage 5 (Dialysis) | 03 | 1.2 |
Table 3.
Domains | Median (IQR) | Mean (SD) | Number of items | Internal consistency (Cronbach’s alpha) |
---|---|---|---|---|
Kidney disease targeted areas | ||||
Symptom/problem domain | 63.6 (50.0–77.3) | 63.1 (18.1) | 12 | 0.769 |
Effects of kidney disease | 75.0 (56.2–87.5) | 71.5 (19.9) | 8 | 0.765 |
Burden of kidney disease | 43.7 (25–62.5) | 46.2 (26.7) | 4 | 0.797 |
Work status | 50.0 (0.0–50.0) | 42.6 (30.9) | 2 | 0.859 |
Cognitive function | 60.0 (40.0–73.3) | 57.9 (26.6) | 3 | 0.570 |
Quality of social interaction | 80.0 (60.0–93.3) | 75.5 (19.7) | 3 | 0.745 |
Sexual function | 100.0 (75.0–100.0) | 84.5 (22.0) | 2 | 0.975 |
Sleep | 62.5 (42.5–77.5) | 59.3 (23.5) | 4 | 0.708 |
Social support | 83.3 (66.7–100.0) | 78.1 (22.6) | 2 | 0.894 |
Hospital staff encouragement | 100.0 (100.0–100.0) | 93.6 (16.0) | 2 | 0.906 |
Patient satisfaction | 66.6 (50.0–83.3) | 58.1 (22.1) | 1 | Not applicable |
Physical Component Summary | ||||
Physical functioning | 50.0 (15.0–75.0) | 46.8 (32.1) | 10 | 0.945 |
Role – physical | 0.0 (0.0–0.0) | 21.1 (39.5) | 4 | 0.975 |
Pain | 35.0 (22.5–57.5) | 40.5 (27.2) | 2 | 0.814 |
General health | 40.0 (30.0–50.0) | 41.1 (18.6) | 5 | 0.701 |
Mental Component Summary | ||||
Emotional well-being | 52.0 (40.0–72.0) | 56.2 (22.6) | 5 | 0.874 |
Role – emotional | 0.0 (0.0–100.0) | 26.6 (43.4) | 3 | 0.981 |
Social function | 62.5 (50.0–100.0) | 66.1 (29.8) | 2 | 0.685 |
Energy/fatigue | 35.0 (20.0–55.0) | 37.7 (24.9) | 4 | 0.725 |
Overall Health | 50.0 (40.0–70.0) | 51.2 (18.9) | 1 | Not applicable |
Exploratory factor analysis for the kidney disease specific component of KDQOL-SF™
The results of the EFA carried out by extracting factors using principal component factoring method identified 14 factors based on the eigenvalue greater than one criteria and those 14 factors were able to acquire 84% of the variability of the initial system. Those 14 factors were rotated using Varimax orthogonal method to make the factors more meaningful. The validity of the 14-factor model was further confirmed by the communalities of each attributes as all the communalities were close to one.
All the items were loaded to one or more domains with factor coefficients of more than 0.4, not requiring any of the items to be dropped (Table 4). However, some items did not load to the factors to which they belong in the original KDQOL SF™ (eg. 14 I, 14 J, 15B, 15G and 18C) and few items showed similarly high factor coefficients in more than one factor. Few items which showed similarly high factor coefficients in more than one factor were assigned to a factor ensuring the pattern in the theoretical framework of the questionnaire based on expert opinion and vigorous analysis of literature.
Table 4.
Domain | Question | F1 | F2 | F3 | F4 | F5 | F6 | F7 | F8 | F9 | F10 | F11 | F12 | F13 | F14 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BKD | 12A | 0.528 | |||||||||||||
12B | 0.513 | ||||||||||||||
12C | 0.556 | ||||||||||||||
12D | 0.405 | ||||||||||||||
QSI | 13A | 0.486 | |||||||||||||
13C | 0.520 | ||||||||||||||
13E | 0.421 | ||||||||||||||
CF | 13B | 0.878 | |||||||||||||
13D | -0.604 | ||||||||||||||
13F | 0.413 | ||||||||||||||
Symptom/problem Domain | 14A | 0.789 | |||||||||||||
14B | −0.503 | ||||||||||||||
14C | 0.855 | ||||||||||||||
14D | 0.744 | ||||||||||||||
14E | 0.870 | ||||||||||||||
14F | −0.823 | ||||||||||||||
14G | 0.433 | ||||||||||||||
14H | 0.774 | ||||||||||||||
14I | 0.629a | ||||||||||||||
14 J | 0.812a | ||||||||||||||
14 K | 0.840 | ||||||||||||||
EKD | 15A | 0.649 | |||||||||||||
15B | 0.710a | ||||||||||||||
15C | 0.681 | ||||||||||||||
15D | 0.489 | ||||||||||||||
15E | 0.405 | ||||||||||||||
15F | 0.725 | ||||||||||||||
15G | 0.551a | ||||||||||||||
15H | 0.610 | ||||||||||||||
SF | 16A | 0.933 | |||||||||||||
16B | 0.907 | ||||||||||||||
Sleep | 17 | 0.878 | |||||||||||||
18A | 0.904 | ||||||||||||||
18B | 0.685 | ||||||||||||||
18C | 0.825a | ||||||||||||||
SS | 19A | 0.805 | |||||||||||||
19B | 0.693 | ||||||||||||||
WS | 20 | 0.802 | |||||||||||||
21 | 0.720 | ||||||||||||||
PS | 23 | 0.509 | |||||||||||||
HSE | 24A | 0.870 | |||||||||||||
24B | 0.879 |
BKD Burden of kidney disease, QSI Quality of social interaction, CF Cognitive function, EKD Effects of kidney disease, SF Sexual function, SS Social support, WS Work status, PS Patient satisfaction, HSE Hospital staff encouragement
aQuestions which did not load to an appropriate factors in accordance with the theoretical background
Convergent and discriminant validity of SF-36 component of KDQOL-SF™
Construct validity of the SF-36 was assessed by evaluating convergent and discriminant validity against WHOQOL – BREF. The Multitrait Multimethod Matrix (MTMM) of correlation coefficients for SF-36 component of KDQOL SF™ and WHOQOL – BREF among study population of the validation study are shown in Fig. 1.
Correlation coefficient observed between the physical functioning domain of SF - 36 and the physical functioning domain of SF-36 was 0.945. Similarly, the reliability coefficients highlighted in yellow which are also the Cronbach alphas were consistently the highest in the matrix showing that the instruments are correlated with itself than with anything else, confirming the reliability of the SF-36 component of KDQOL SF™.
Validity coefficients which are the correlations between the same dimensions of the two instruments highlighted in blue in the Fig. 1 were high except in the social functioning domain. This provided evidence for convergent validity of the SF-36 component of KDQOL SF™.
Correlations that differ in both, dimension and the instrument were the lowest in the matrix highlighted by the correlation observed between the emotional wellbeing domain of SF-36 and the physical health domain of WHOQOL-BREF among the study participants of the validation study (r = 0.291) being much lower than the correlation observed between the emotional wellbeing domain of SF-36 and the psychological health domain of WHOQOL-BREFF (r = 0.526), confirming that the SF-36 component of KDQOL SF™ is showing discriminant validity.
Reliability of KDQOL-SF™
Cronbach’s alpha of all domains of KDQOL SF™ except for cognitive function and Social function, exceeded Nunnally's criteria of 0.7 which can be considered adequate internal consistency (Table 3). The Intra class Correlation Coefficients were more than 0.8 for all the domains indicating good test re-test reliability.
Discussion
The KDQOL SF™ is a CKD specific study instrument. The use of specific tools to assess the QOL has been found to generate results which can be readily translated to relevant recommendations to uplift the QOL of the diseased. Such specific assessments are also more acceptable to nephrology fraternity. KDQOL SF™ is a tool that has been used widely in the world to assess HRQOL among CKD patients [8], making the results generated comparable to evaluate the differences. The mean completion time of the tool was found to be approximately 20 min which is shorter than in many other QOL instruments [15].
The present study validated the KDQOL SF for Sri Lanka and this is the first attempt in Sri Lanka to validate a QOL instrument for CKD patients. Though KDQOL SF™ has been validated and used in many countries with evidence of high validity and reliability [16], it was imperative that the tool be culturally adapted and the validity of the tool to assess QOL of the CKD patients in the Sri Lankan rural community be assessed prior to use [8].
The KDQOL SF™ comprises two clearly defined components; Kidney Disease Specific Component and SF-36. The SF 36 component of the KDQOL SF™ has previously been culturally adapted, translated and validated in different settings in Sri Lanka [11] and the present study used the validated version to improve the efficiency of the study. The cultural adaptation of the Kidney Disease Specific Component was through the guidance of a panel of experts using the Delphi technique. The service of a panel of experts from different professional backgrounds, some of whom have been directly involved in the caring of CKD patients in Anuradhapura district, enabled the cultural suitability to be assessed in different perspectives. The use of the Delphi technique instead of face to face consultative meetings had the advantage of not requiring the experts to take time off their schedules to contribute to the study. It allowed the experts to respond at any time convenient to them and to contact any source of information if needed. Further, this process facilitated the independence of forming opinion and perspectives [10].
Exploratory Factor Analysis performed using Principal Component Analysis revealed the measures of sample adequacy, Kaiser-Meyer-Okin measure to be close to one (0.791) and Bartlett’s Test for Sphericity to be statistically significant, indicating that the sample was adequate. Results of EFA on kidney disease specific component of KDQOL-SF™ revealed 14 factors with Eigen values more than one (ranging from 1.062–8.746),when factors were extracted using PCA. PCA is an accepted method of selecting factors in EFA [17]. The total variance explained by the model was 84.1% which indicate that the 14 factors identified explain the 84.1% of the total variability of 43 items in the original kidney disease specific component of KDQOL-SF™, which can be considered acceptable. The communalities extracted for domains were all high, (ranging from 0.711 to 0.951) which indicated high correlation between the items. Though within each factor, all the items loaded into one or more factors, not requiring any of the items to be dropped, cross loadings were apparent between some factors (eg; 12A, 13E, 14B) which can be explained by the overlapping nature of assessed variables.
The study adopted a process, so that the factor structure was not decided solely based on statistical results, but by an approach suggested by the experts and global literature.
Exploratory Factor Analysis performed on the Kidney Disease Specific Component has yielded different results globally. EFA performed on a modified Egypt version of KDQOL SF™, has resulted in a ten factor model explaining 70.9% of the variability [8]. When principal components analysis was performed, all 43 items explained 79.81% of the total variance in 11 factors in the Iranian version [16]. QOL is a construct which is very much related to the socio-cultural and economical background of a setting, thus these different results found in different settings could be attributed to these differences.
The Multitrait Multimethod Matrix (MTMM) of correlation coefficients, performed to assess convergent and discriminant validity of the SF-36 component of KDQOL SF™, resulted in the expected correlations for convergent and discriminant validity except in the social functioning. This can be taken as evidence of good validity of the SF-36 component of KDQOL-SF™ to assess HRQOL of CKD patients in Sri Lanka. The finding of poor correlation in the domain of social functioning was also experienced by the previous researchers. Kumarapeli [12] and Dundar et al. [18] have reports on two validation studies, between WHOQOL-BREFF and SF 36, where good correlation was found in both physical and psychological domains, but poor correlation in the social domain (0.276 and 0.393 respectively).
The internal consistency of both components of KDQOL-SF™ was assessed by calculating the Cronbach’s alpha which exceeded Nunnally's criteria of 0.7 in all domains except for cognitive function (0.570) and Social function (0.685) indicating good internal consistency [14]. Social function domain is assessed using two items in KDQOL-SF™ and cognitive function is assessed using three items and these limited number of items assess diverse aspects of respective domains. In addition, the complexity of the social functions in a rural community in Sri Lanka, could be the reasons for relatively low internal consistency of the two domains.
Low internal consistency in Social function domain of KDQOL-SF™ is also a common finding across the world in validation studies. Similarly the Singapore version had low internal consistency in Social function (0.66) but all the other domains had Cronbach’s α of more than 0.70 [19]. Cronbach’s α was 0.64 in the cognitive function domain of the Korean version but it was 0.73 in the social function domain [20]. The Egypt version had the Cronbach’s α value more than 0.7 for all the domains other than social interaction (0.23) and work status (0.28) [8] while the Cronbach’s α value was more than 0.7 in all the domains in the Iranian version [16].
The test re-test Spearman’s correlations were more than 0.7 for all the domains indicating good test re-test reliability. Similar findings were evident in Egypt version [8], Iranian version [16] and in Korean version [20].
There were some limitations to this study. First, the patients were recruited from one district only, which may limit the generalizability of the findings to Sri Lanka. Second, some of the information related to HRQOL is considered to be sensitive in nature and the fact that this information was obtained utilizing an interviewer-administered questionnaire could have led to some under-reporting in the assessment of HRQOL, though many measures were taken to minimize this issue.
Conclusion
The results of the validation study indicated that KDQOL-SF™ is a valid and reliable instrument which can be used to assess HRQOL of CKD patients.
Acknowledgements
We would like to thank all patients who voluntarily participated in the study.
Funding
This study was funded by the Ministry of Health, Sri Lanka
Availability of data and materials
All data underlying the findings are within the paper.
Authors’ contributions
SS: Research idea, study design, statistical analysis and drafting of the manuscript. NG: study design, data analysis/interpretation, supervision and mentorship. PP and SK: data interpretation, supervision. TSGP: data analysis/interpretation. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interest.
Consent for publication
Not applicable.
Ethics approval and consent to participate
The study is in accordance with Helsinki Declaration. The study protocol has been approved by the Ethics Committee of Colombo Medical Faculty. Participants gave their informed consent.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Sameera Senanayake, Phone: +94772928226, Email: sam197902@gmail.com.
Nalika Gunawardena, Email: nalikaguna@hotmail.com.
Paba Palihawadana, Email: ppalihawadana@unicef.org.
Sanjeewa Kularatna, Email: sanjeewa.kularatna@qut.edu.au.
T. S. G. Peiris, Email: sarathp@uom.lk
References
- 1.Alebiosu CO, Ayodele OE. The global burden of chronic kidney disease and the way forward. Ethn Dis. 2005;15(3):418–423. [PubMed] [Google Scholar]
- 2.Skevington SM, Lotfy M, O’Connell KA. The World Health Organization’s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial a report from the WHOQOL group. Qual Life Res. 2004;13(2):299–310. doi: 10.1023/B:QURE.0000018486.91360.00. [DOI] [PubMed] [Google Scholar]
- 3.Duarte PS, Ciconelli RM, Sesso R. Cultural adaptation and validation of the “kidney disease and quality of life--short form (KDQOL-SF 1.3)” in Brazil. Braz J Med Biol Res. 2005;38(2):261–270. doi: 10.1590/S0100-879X2005000200015. [DOI] [PubMed] [Google Scholar]
- 4.Rebollo-Rubio A, Morales-Asencio JM, Pons-Raventos ME, Mansilla-Francisco JJ. Revisi??n de estudios sobre calidad de vida relacionada con la salud en la enfermedad renal cr??nica avanzada en Espa??a. Nefrologia. 2015;35(1):92–109. doi: 10.3265/Nefrologia.pre2014.Jul.12133. [DOI] [PubMed] [Google Scholar]
- 5.Mujais SK, Story K, Brouillette J, Takano T, Soroka S, Franek C, et al. Health-related quality of life in CKD patients: correlates and evolution over time. Clin J Am Soc Nephrol. 2009;4(8):1293–1301. doi: 10.2215/CJN.05541008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Tsai YC, Hung CC, Hwang SJ, Wang SL, Hsiao SM, Lin MY, Kung LF, Hsiao PN, Chen HC, et al. Quality of life predicts risks of end-stage renal disease and mortality in patients with chronic kidney disease. Nephrol Dial Transplant. 2010;25(5):1621–26. doi:10.1093/ndt/gfp671. [DOI] [PubMed]
- 7.DeOreo PB. Hemodialysis patient-assessed functional health status predicts continued survival, hospitalization, and dialysis-attendance compliance. Am J Kidney Dis Elsevier. 1997;30(2):204–212. doi: 10.1016/S0272-6386(97)90053-6. [DOI] [PubMed] [Google Scholar]
- 8.Abd El Hafeez S, Sallam SA, Gad ZM, Zoccali C, Torino C, Tripepi G, et al. Cultural adaptation and validation of the “kidney disease and quality of life--short form (KDQOL-SF™) version 1.3” questionnaire in Egypt. BMC Nephrol. 2012;13(1):170. doi: 10.1186/1471-2369-13-170. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Czyżewski L, Sańko-Resmer J, Wyzgał J, Kurowski A. Assessment of health-related quality of life of patients after kidney transplantation in comparison with hemodialysis and peritoneal dialysis. Ann Transplant Q Polish Transplant Soc. 2013;19:576–585. doi: 10.12659/AOT.891265. [DOI] [PubMed] [Google Scholar]
- 10.Hsu CC, Sandford BA. The Delphi technique: making sense of consensus. Pract Assessment Res Eval. 2007;12(10):1–8. [Google Scholar]
- 11.Gunawardena NS. Factors affecting functional outcome of lower limb amputee soldiers in two Districts of Sri Lanka. MD (Comunity Medicine), University of Colombo.; 2002.
- 12.Kumarapeli KADDVL. Prevalence of rep roductive endocrine d isorders, health s eeking behavior, consequences and risk factors of polycystic ovary syndrome among women of reproductive in Gampaha District. Sri Lanka: University of Colombo; 2006. [Google Scholar]
- 13.Litwin MS. How to measure survey reliability and validity. Vol. 7. California: Sage Publications; 1995.
- 14.Abramson J, Abramson ZH. Research methods in community medicine: surveys, epidemiological research, programme evaluation, clinical trials. New Jersey: Wiley; 2011.
- 15.Ter Bogt TFM, van Dorsselaer SAFM, Monshouwer K, Verdurmen JEE, Engels RCME, Vollebergh WAM. Body mass index and body weight perception as risk factors for internalizing and externalizing problem behavior among adolescents. J Adolesc Health. 2006;39(1):27–34. doi: 10.1016/j.jadohealth.2005.09.007. [DOI] [PubMed] [Google Scholar]
- 16.Pakpour AH, Yekaninejad M, Molsted S, Harrison AP, Hashemi F, Saffari M. Translation, cultural adaptation assessment, and both validity and reliability testing of the kidney disease quality of life - short form version 1.3 for use with Iranian patients. Nephrology. 2011;16(1):106–112. doi: 10.1111/j.1440-1797.2010.01389.x. [DOI] [PubMed] [Google Scholar]
- 17.Wu T. The validity and reliability of safety leadership scale in universities of Taiwan. Int J Technol Eng Educ. 2005;2(1):27–42. [Google Scholar]
- 18.Dündar P, Fidaner C, Fidaner H, Oral A, Eser S, Atman U. Comparing the Turkish versions of WHOQOL-BREF and SF-36. Convergent validity of WHOQOL-BREF and SF-36. Hippokratia. 2002;6(1):37–43. [Google Scholar]
- 19.Joshi VD, Mooppil N, Lim JF. Validation of the kidney disease quality of life-short form: a cross-sectional study of a dialysis-targeted health measure in Singapore. BMC Nephrol. BioMed Central Ltd. 2010;11(1):36. doi: 10.1186/1471-2369-11-36. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Park HJ, Kim S, Yong JS, Han SS, Yang DH, Meguro M, et al. Reliability and validity of the Korean version of kidney disease quality of life instrument (KDQOL-SF) Tohoku J Exp Med. 2007;211(4):321–329. doi: 10.1620/tjem.211.321. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
All data underlying the findings are within the paper.